Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

CC40.8 antibody confers protection against SARS-CoV-2 infection

Feb. 22, 2022

Guangzhou Henovcom Bioscience discloses new antivirals

Feb. 21, 2022

Monoclonal antibodies in AR-701 cocktail neutralize SARS-CoV-2 Omicron variant

Feb. 18, 2022

Asep advances antibiofilm peptide technology for wound dressings

Feb. 17, 2022

BioVaxys reports ACE2 binding inhibition data with haptenized SARS-CoV-2 vaccine BVX-0320

Feb. 17, 2022

Alvea's SARS-CoV-2 DNA vaccine Alveavax enters preclinical testing

Feb. 17, 2022

TRIM13 prevents pathogenic DNA-triggered inflammatory responses

Feb. 17, 2022

Enanta Pharmaceuticals describes SARS-CoV-2 3C-like proteinase inhibitors

Feb. 17, 2022

Memo Therapeutics to advance lead programs

Feb. 16, 2022

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Feb. 16, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...